Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01832480 · ClinicalTrials.gov registry record · Phase 3
Trichomonas Vaginalis Repeat Infections Among HIV Negative Women
A Phase 3 study, sponsored by Tulane University Health Sciences Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 623
- Enrollment target
NCT01832480 is a Phase 3 study that has completed, run by Tulane University Health Sciences Center. The registered enrollment target is 623 participants.
The verdict
NCT01832480, a Phase 3 study, has completed, sponsored by Tulane University Health Sciences Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 623 participants
- Enrollment target
Study Summary
The overall goal of this project is to determine the influence of patient treatment and host factors on repeat Trichomonas vaginalis (TV) infections among HIV-negative women
Interventions
- DRUG MTZ 500 mg twice daily x 7 days
- DRUG MTZ 2 g
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 623 participants |
| Start Date | 2014-10-06 |
| Est. Completion | 2017-06-05 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01832480
The ClinicalTrials.gov registry entry for NCT01832480 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 623 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tulane University Health Sciences Center, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which MTZ 500 mg twice daily x 7 days is the first listed.
NCT01832480 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01832480 about?
NCT01832480 is a clinical study titled "Trichomonas Vaginalis Repeat Infections Among HIV Negative Women". The overall goal of this project is to determine the influence of patient treatment and host factors on repeat Trichomonas vaginalis (TV) infections among HIV-negative women
What is the current status of trial NCT01832480?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 623 participants. The study started on 2014-10-06. Estimated completion is 2017-06-05.
What interventions are being tested in trial NCT01832480?
The interventions under investigation include: MTZ 500 mg twice daily x 7 days (DRUG), MTZ 2 g (DRUG).
Who is sponsoring clinical trial NCT01832480?
This trial is sponsored by Tulane University Health Sciences Center, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.